Skip to main content
Top
Published in: International Urology and Nephrology 6/2012

01-12-2012 | Nephrology – Original Paper

Adult patients with sporadic polycystic kidney disease: the importance of screening for mutations in the PKD1 and PKD2 genes

Authors: Hartmut P. H. Neumann, Janina Bacher, Zinaida Nabulsi, Nadine Ortiz Brüchle, Michael M. Hoffmann, Elke Schaeffner, Jens Nürnberger, Markus Cybulla, Jochen Wilpert, Peter Riegler, Robert Corradini, Annette Kraemer-Guth, Pablo Azurmendi, Mercedes Nunez, Sven Gläsker, Klaus Zerres, Cordula Jilg

Published in: International Urology and Nephrology | Issue 6/2012

Login to get access

Abstract

Background

ADPKD is one of the most common inherited disorders, with high risk for end-stage renal disease. Numerous patients, however, have no relatives in whom this disorder is known and are unsure whether they may transmit the disease to their offsprings. The aim of this study was to evaluate whether germline mutation analysis adds substantial information to clinical symptoms for diagnosis of ADPKD in these patients.

Methods

Clinical data included renal function and presence of liver or pancreas cysts, heart valve insufficiency, intracranial aneurysms, colonic diverticles, and abdominal hernias. Family history was evaluated regarding ADPKD. Germline mutation screening of the PKD1 and PKD2 genes was performed for intragenic mutations and for large deletions.

Results

A total of 324 adult patients with ADPKD including 30 patients without a family history of ADPKD (sporadic cases) were included. PKD1 mutations were found in 24/30 and PKD2 mutations in 6 patients. Liver cysts were present in 14 patients and intracranial aneurysms in 2 patients. Fourteen patients (45%) had no extrarenal involvement. Compared to the 294 patients with familial ADPKD, the clinical characteristics and the age at the start of dialysis were similar in those with sporadic ADPKD.

Conclusion

The clinical characteristics of patients with sporadic and familial ADPKD are similar, but sporadic ADPKD is often overlooked because of the absence of a family history. Molecular genetic screening for germline mutations in both PKD1 and PKD2 genes is essential for the definitive diagnosis of ADPKD.
Literature
6.
go back to reference Chatha RK, Johnson AM, Rothberg PG, Townsend RR, Neumann HP, Gabow PA (2001) Von Hippel-Lindau disease masquerading as autosomal dominant polycystic kidney disease. Am J Kidney Dis 37(4):852–858PubMedCrossRef Chatha RK, Johnson AM, Rothberg PG, Townsend RR, Neumann HP, Gabow PA (2001) Von Hippel-Lindau disease masquerading as autosomal dominant polycystic kidney disease. Am J Kidney Dis 37(4):852–858PubMedCrossRef
7.
go back to reference Neumann HP (1999) The spectrum of renal cysts in adulthood—discussion of eight cases. Nephrol Dial Transplant 14(9):2234–2244PubMedCrossRef Neumann HP (1999) The spectrum of renal cysts in adulthood—discussion of eight cases. Nephrol Dial Transplant 14(9):2234–2244PubMedCrossRef
8.
go back to reference Reeders ST, Breuning MH, Davies KE, Nicholls RD, Jarman AP, Higgs DR, Pearson PL, Weatherall DJ (1985) A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16. Nature 317(6037):542–544PubMedCrossRef Reeders ST, Breuning MH, Davies KE, Nicholls RD, Jarman AP, Higgs DR, Pearson PL, Weatherall DJ (1985) A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16. Nature 317(6037):542–544PubMedCrossRef
9.
go back to reference Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, Reynolds DM, Cai Y, Gabow PA, Pierides A, Kimberling WJ, Breuning MH, Deltas CC, Peters DJ, Somlo S (1996) PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272(5266):1339–1342PubMedCrossRef Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, Reynolds DM, Cai Y, Gabow PA, Pierides A, Kimberling WJ, Breuning MH, Deltas CC, Peters DJ, Somlo S (1996) PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272(5266):1339–1342PubMedCrossRef
10.
go back to reference The European Polycystic Kidney Disease Consortium (1994) The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 78(4):725 The European Polycystic Kidney Disease Consortium (1994) The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 78(4):725
11.
go back to reference The European Polycystic Kidney Disease Consortium (1994) The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 77(6):881–894CrossRef The European Polycystic Kidney Disease Consortium (1994) The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 77(6):881–894CrossRef
12.
go back to reference Rossetti S, Burton S, Strmecki L, Pond GR, San Millan JL, Zerres K, Barratt TM, Ozen S, Torres VE, Bergstralh EJ, Winearls CG, Harris PC (2002) The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease. J Am Soc Nephrol 13(5):1230–1237PubMedCrossRef Rossetti S, Burton S, Strmecki L, Pond GR, San Millan JL, Zerres K, Barratt TM, Ozen S, Torres VE, Bergstralh EJ, Winearls CG, Harris PC (2002) The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease. J Am Soc Nephrol 13(5):1230–1237PubMedCrossRef
13.
go back to reference Wu G, Hayashi T, Park JH, Dixit M, Reynolds DM, Li L, Maeda Y, Cai Y, Coca-Prados M, Somlo S (1998) Identification of PKD2L, a human PKD2-related gene: tissue-specific expression and mapping to chromosome 10q25. Genomics 54(3):564–568. doi:10.1006/geno.1998.5618 PubMedCrossRef Wu G, Hayashi T, Park JH, Dixit M, Reynolds DM, Li L, Maeda Y, Cai Y, Coca-Prados M, Somlo S (1998) Identification of PKD2L, a human PKD2-related gene: tissue-specific expression and mapping to chromosome 10q25. Genomics 54(3):564–568. doi:10.​1006/​geno.​1998.​5618 PubMedCrossRef
14.
go back to reference Rossetti S, Chauveau D, Kubly V, Slezak JM, Saggar-Malik AK, Pei Y, Ong AC, Stewart F, Watson ML, Bergstralh EJ, Winearls CG, Torres VE, Harris PC (2003) Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Lancet 361(9376):2196–2201. doi:10.1016/S0140-6736(03)13773-7 PubMedCrossRef Rossetti S, Chauveau D, Kubly V, Slezak JM, Saggar-Malik AK, Pei Y, Ong AC, Stewart F, Watson ML, Bergstralh EJ, Winearls CG, Torres VE, Harris PC (2003) Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Lancet 361(9376):2196–2201. doi:10.​1016/​S0140-6736(03)13773-7 PubMedCrossRef
15.
go back to reference Grantham R (1974) Amino acid difference formula to help explain protein evolution. Science 185(4154):862–864PubMedCrossRef Grantham R (1974) Amino acid difference formula to help explain protein evolution. Science 185(4154):862–864PubMedCrossRef
Metadata
Title
Adult patients with sporadic polycystic kidney disease: the importance of screening for mutations in the PKD1 and PKD2 genes
Authors
Hartmut P. H. Neumann
Janina Bacher
Zinaida Nabulsi
Nadine Ortiz Brüchle
Michael M. Hoffmann
Elke Schaeffner
Jens Nürnberger
Markus Cybulla
Jochen Wilpert
Peter Riegler
Robert Corradini
Annette Kraemer-Guth
Pablo Azurmendi
Mercedes Nunez
Sven Gläsker
Klaus Zerres
Cordula Jilg
Publication date
01-12-2012
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 6/2012
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-012-0125-0

Other articles of this Issue 6/2012

International Urology and Nephrology 6/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.